AneuFix Polymer Sac Filling

(in development)

What if EVAR could truly be a long-term solution?

TripleMed’s AneuFix is used to fill the entire aneurysm sac around an EVAR endograft during the same procedure in which the endograft is placed. It is designed to transform EVAR by eliminating sac growth and preventing reinterventions, turning it into a first-time-right procedure.

Clinical studies are ongoing to demonstrate effectiveness, performance and safety of AneuFix for this indication.

1

Prevent endo leaks

AneuFix creates a durable and stable implant that shows promise to effectively prevent Type II Endoleaks in. (based on FIM clinical study results, see section ‘Validation’).

2

Stop sac growth

By preventing type II Endoleaks, AneuFix polymer will slow the progression of aneurysm sac expansion.

3

Endograft stability

AneuFix polymer is designed to encapsulate the endograft in order to stabilize the endograft and through this reduce the risk of migration.

Because good enough sometimes just isn’t good enough

Many aortic aneurysm patients, after undergoing an EVAR procedure, face ongoing uncertainty, requiring regular check-ups while knowing the aneurysm “time bomb” is still quietly ticking. We believe in changing lives, not just clinical outcomes, and are dedicated to perfecting the EVAR procedure. Elevating the standard of care and ensuring patients can return to their daily lives without worry and fully live their lives again.

More about us

Reducing strain on healthcare systems with fewer check-ups and complications

Patients

No more “ticking time bomb”, our aim is to improve treatment of the aortic aneurysm, allowing patients to live their lives free from the worry of rupture.

Surgeons

By addressing aortic aneurysm sac growth, Aneufix allows surgeons to confidently send patients home knowing the problem is optimally treated, providing peace of mind.

Hospitals

Aneufix is designed to reduce frequency of check-ups and minimize complications, easing the burden on healthcare systems while improving patient outcomes.

Prof. Dr. Eric L.G. Verhoeven
‍Chief, Department of Vascular and Endovascular Surgery Klinikum Nuremberg

"TripleMed's innovation introduces a paradigm shift in AAA treatment. Prophylactic Sac Filling holds the promise to provide a curative solution for AAA, by completely filling the aneurysm sac and preventing reinterventions."